Swedish drugmaker SOBI agrees $8b takeover bid from Advent, Singapore's GIC

Swedish drugmaker Orphan Biovitrum (SOBI) has agreed an $8 billion takeover by U.S. private equity firm Advent International and Singapore’s sovereign wealth fund, boosting its shares on speculation of a higher offer.